Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

V. Reliquet · SciRah

Researcher profile · Semantic Scholar

V. Reliquet

Share profile

V. Reliquet — researcher profile on SciRah

h-index: 22
Works: 77
Citations: 1,708

Most-cited papers

No perinatal HIV-1 transmission from women with effective antiretroviral therapy starting before conception.
L. Mandelbrot, R. Tubiana, J. le Chenadec, C. Dollfus +14 more
2015Clinical Infectious Diseases295 citations
Semantic Scholar
Prevalence and Risk Factors of Sleep Disturbance in a Large HIV-Infected Adult Population
C. Allavena, T. Guimard, E. Billaud, S. De la Tullaye +9 more
2016Aids and Behavior103 citations
Semantic Scholar
Increased risk of serious bacterial infections due to maternal immunosuppression in HIV-exposed uninfected infants in a European country.
C. Taron-Brocard, J. le Chenadec, A. Faye, C. Dollfus +238 more
2014Clinical Infectious Diseases87 citations Open access
Semantic Scholar
A prospective study of criteria for the diagnosis of toxoplasmic encephalitis in 186 AIDS patients
F. Raffi, J. Aboulker, C. Michelet, V. Reliquet +7 more
1997AIDS (London)82 citations Open access
Semantic Scholar
Dolutegravir and lamivudine maintenance therapy in HIV-1 virologically suppressed patients: results of the ANRS 167 trial (LAMIDOL)
V. Joly, C. Burdet, R. Landman, M. Vigan +39 more
2018Journal of Antimicrobial Chemotherapy75 citations
Semantic Scholar
A liquid chromatography-tandem mass spectrometry assay for quantification of nevirapine, indinavir, atazanavir, amprenavir, saquinavir, ritonavir, lopinavir, efavirenz, tipranavir, darunavir and maraviroc in the plasma of patients infected with HIV.
J. Martin, G. Deslandes, E. Dailly, C. Renaud +3 more
2009Journal of chromatography. B, Analytical technologies in the biomedical and life sciences62 citations
Semantic Scholar
Increased Aldosterone Among HIV-Infected Women with Visceral Fat Accumulation
I. Thuret, M. Chaix, C. Tamalet, V. Reliquet +6 more
2009AIDS (London)52 citations Open access
Semantic Scholar
Integrase strand transfer inhibitors and neuropsychiatric adverse events in a large prospective cohort
L. Cuzin, P. Pugliese, Christine Katlama, F. Bani-Sadr +268 more
2018Journal of Antimicrobial Chemotherapy51 citations
Semantic Scholar
The Virgo Study: Nevirapine, Didanosine and Stavudine Combination Therapy in Antiretroviral-Naive HIV-1-Infected Adults
F. Raffi, V. Reliquet, V. Ferré, C. Arvieux +11 more
1999Antiviral Therapy51 citations Open access
Semantic Scholar
Substitution of a nonnucleoside reverse transcriptase inhibitor for a protease inhibitor in the treatment of patients with undetectable plasma human immunodeficiency virus type 1 RNA.
F. Raffi, B. Bonnet, V. Ferré, Jean-Luc Esnault +6 more
2000Clinical Infectious Diseases49 citations Open access
Semantic Scholar
Health-related quality of life and health locus of control beliefs among HIV-infected treated patients.
M. Préau, E. Vincent, B. Spire, V. Reliquet +4 more
2005Journal of Psychosomatic Research46 citations
Semantic Scholar
Dolutegravir monotherapy versus dolutegravir/abacavir/lamivudine for virologically suppressed people living with chronic HIV infection: the randomized non-inferiority MONCAY trial.
L. Hocqueloux, F. Raffi, T. Prazuck, L. Bernard +45 more
2019Clinical Infectious Diseases43 citations
Semantic Scholar
No relationship between high nevirapine plasma concentration and hepatotoxicity in HIV-1-infected patients naive of antiretroviral treatment or switched from protease inhibitors
E. Dailly, E. Billaud, V. Reliquet, S. Breurec +5 more
2004European Journal of Clinical Pharmacology41 citations
Semantic Scholar
Immediate Versus Deferred Switching From a Boosted Protease Inhibitor–based Regimen to a Dolutegravir-based Regimen in Virologically Suppressed Patients With High Cardiovascular Risk or Age ≥50 Years: Final 96-Week Results of the NEAT022 Study
J. Gatell, L. Assoumou, Graeme Moyle, Laura Waters +107 more
2018Clinical Infectious Diseases39 citations Open access
Semantic Scholar
Incidence of diabetes in HIV-infected patients treated with first-line integrase strand transfer inhibitors: a French multicentre retrospective study.
A. Ursenbach, Vincent Max, M. Maurel, F. Bani-Sadr +297 more
2020Journal of Antimicrobial Chemotherapy33 citations
Semantic Scholar
Metabolic risk factors in young adults infected with HIV since childhood compared with the general population
E. Arrivé, J. Viard, B. Salanave, C. Dollfus +6 more
2018PLoS ONE33 citations Open access
Semantic Scholar
Peripheral neuropathy during stavudine‐didanosine antiretroviral therapy
V. Reliquet, J. Mussini, J. Chennebault, A. Lafeuillade +1 more
2001HIV Medicine31 citations
Semantic Scholar
Prevalence and risk factors of sleep disturbances in a large HIV-infected adult population
C. Allavena, T. Guimard, E. Billaud, Sylvie de la Tullaye +9 more
2014Journal of the International AIDS Society26 citations Open access
Semantic Scholar
Risk of cancer in children exposed to didanosine in utero
Mira Hleyhel, S. Goujon, C. Delteil, A. Vasiljevic +11 more
2016AIDS (London)25 citations
Semantic Scholar
Risk of birth defects and perinatal outcomes in HIV-infected women exposed to integrase strand inhibitors during pregnancy.
J. Sibiude, J. le Chenadec, L. Mandelbrot, C. Dollfus +8 more
2020AIDS (London)24 citations Open access
Semantic Scholar
Cytochrome 2B6 polymorphism and efavirenz‐induced central nervous system symptoms : a substudy of the ANRS ALIZE trial
S. Gallien, Valérie Journot, M. Loriot, H. Sauvageon +5 more
2017HIV Medicine23 citations
Semantic Scholar
Nevirapine–Raltegravir Combination, An Nrti and Pi/R Sparing Regimen, as Maintenance Antiretroviral Therapy in Virologically Suppressed HIV-1-Infected Patients
V. Reliquet, C. Chirouze, C. Allavena, P. Muret +6 more
2013Antiviral Therapy23 citations Open access
Semantic Scholar
Effect of twice-daily nevirapine on adherence in HIV-1-infected patients: a randomized controlled study
J. Parienti, V. Massari, V. Reliquet, F. Chaillot +4 more
2007AIDS (London)23 citations Open access
Semantic Scholar
Twelve-Year Experience of Nevirapine Use: Benefits and Convenience for Long-Term Management in a French Cohort of HIV-1–Infected Patients
V. Reliquet, C. Allavena, P. M. Houssine, O. Mounoury +1 more
2010HIV Clinical Trials22 citations Open access
Semantic Scholar
Efficacy and safety of stavudine and didanosine combination therapy in antiretroviral‐experienced patients
F. Raffi, V. Reliquet, Sylvie Auger, J. Besnier +7 more
1998AIDS (London)22 citations Open access
Semantic Scholar
Switching from tenofovir/emtricitabine and nevirapine to a tenofovir/emtricitabine/rilpivirine single-tablet regimen in virologically suppressed, HIV-1-infected subjects.
C. Allavena, É. Dailly, V. Reliquet, B. Bonnet +8 more
2014Journal of Antimicrobial Chemotherapy21 citations Open access
Semantic Scholar
Use of an Itraconazole/allopurinol combination for the treatment of visceral leishmaniasis in a patient with AIDS.
François Raffi, D. Merrien, P. Le Pape, V. Reliquet
1995Clinical Infectious Diseases19 citations
Semantic Scholar
Direct-acting antiviral treatment against hepatitis C virus infection in HIV-Infected patients - "En route for eradication"?
P. Pradat, P. Puglièse, I. Poizot-Martin, M. Valantin +207 more
2017Journal of Infection18 citations
Semantic Scholar
Efficacy of Nevirapine-Based HAART in HIV-1-Infected, Treatment-Naive Persons with High and Low Baseline Viral Loads
F. Raffi, V. Reliquet, D. Podzamczer, R. Pollard
2001HIV Clinical Trials18 citations
Semantic Scholar
Tenofovir DF/emtricitabine/rilpivirine as HIV post-exposure prophylaxis: results from a multicentre prospective study
M. Chauveau, E. Billaud, B. Bonnet, D. Merrien +28 more
2019Journal of Antimicrobial Chemotherapy17 citations
Semantic Scholar
Efficacy and Safety of an NRTI-Sparing Dual Regimen of Raltegravir and Ritonavir-Boosted Protease Inhibitor in a Triple Antiretroviral Class-Experienced Population
C. Allavena, O. Mounoury, A. Rodallec, V. Reliquet +2 more
2009HIV Clinical Trials15 citations Open access
Semantic Scholar
Role and evolution of viral tropism in patients with advanced HIV disease receiving intensified initial regimen in the ANRS 130 APOLLO trial.
C. Charpentier, V. Joly, L. Larrouy, C. Fagard +241 more
2013Journal of Antimicrobial Chemotherapy14 citations
Semantic Scholar
Evaluation of residual viremia and quantitation of soluble CD14 in a large cohort of HIV‐infected adults on a long‐term non‐nucleoside reverse transcriptase inhibitor‐based regimen
C. Allavena, A. Rodallec, S. Secher, V. Reliquet +5 more
2013Journal of Medical Virology14 citations
Semantic Scholar
Reaching the Second and Third Joint United Nations Programme on HIV/AIDS 90-90-90 Targets Is Accompanied by a Dramatic Reduction in Primary Human Immunodeficiency Virus (HIV) Infection and in Recent HIV Infections in a Large French Nationwide HIV Cohort.
A. Le Guillou, P. Puglièse, François Raffi, A. Cabié +245 more
2019Clinical Infectious Diseases13 citations
Semantic Scholar
A population approach to study the influence of nevirapine administration on lopinavir pharmacokinetics in HIV-1 infected patients
E. Dailly, V. Reliquet, F. Raffi, P. Jolliet
2005European Journal of Clinical Pharmacology12 citations
Semantic Scholar
Treatment interruption for virological failure or as sparing regimen in children with chronic HIV-1 infection
F. Monpoux, J. Tricoire, M. Lalande, V. Reliquet +2 more
2004AIDS (London)12 citations
Semantic Scholar
Nucleoside/nucleotide reverse transcriptase inhibitor sparing regimen with once daily integrase inhibitor plus boosted darunavir is non-inferior to standard of care in virologically-suppressed children and adolescents living with HIV – Week 48 results of the randomised SMILE Penta-17-ANRS 152 clinic
A. Compagnucci, Man K. Chan, Y. Saïdi, T. Cressey +29 more
2023EClinicalMedicine11 citations Open access
Semantic Scholar
Kaposi sarcoma among people living with HIV in the French DAT’AIDS cohort between 2010 and 2015
I. Poizot-Martin, V. Obry-Roguet, C. Duvivier, C. Lions +288 more
2020Journal of the European Academy of Dermatology and Venereology11 citations Open access
Semantic Scholar
Specific anti-toxoplasmic IgG antibody immunoblot profiles in patients with AIDS-associated Toxoplasma encephalitis.
F. Raffi, J. Franck, H. Pelloux, Francis Derouin +5 more
1999Diagnostic microbiology and infectious disease11 citations
Semantic Scholar
Influence of nevirapine administration on the pharmacokinetics of dolutegravir in patients infected with HIV-1.
E. Dailly, C. Allavena, M. Grégoire, V. Reliquet +8 more
2015Journal of Antimicrobial Chemotherapy10 citations Open access
Semantic Scholar
Effectiveness and safety of saquinavir/ritonavir in HIV-infected pregnant women: INEMA cohort.
C. Brunet, V. Reliquet, T. Jovelin, N. Venisse +6 more
2012Médecine et maladies infectieuses10 citations Open access
Semantic Scholar
Long‐term assessment of nevirapine‐containing highly active antiretroviral therapy in antiretroviral‐naive HIV‐infected patients: 3‐year follow‐up of the VIRGO study
V. Reliquet, C. Allavena, C. François-Brunet, P. Perré +6 more
2006HIV Medicine10 citations Open access
Semantic Scholar
Patient-reported symptoms during direct-acting antiviral treatment: A real-life study in HIV-HCV coinfected patients (ANRS CO13 HEPAVIH).
F. Marcellin, Vincent Di Beo, Hugues Aumaitre, M. Mora +291 more
2020Journal of Hepatology9 citations Open access
Semantic Scholar
Breakthrough cerebral toxoplasmosis in patients with AIDS who are being treated with clarithromycin.
François Raffi, L. Struillou, E. Ninin, V. Reliquet +2 more
1995Clinical Infectious Diseases9 citations
Semantic Scholar
Pharmacokinetic modelling of darunavir/ritonavir dose reduction (800/100 to 400/100 mg once daily) in a darunavir/ritonavir-containing regimen in virologically suppressed HIV-infected patients: ANRS 165 DARULIGHT sub-study
M. Lê, M. Chaix, S. Chevret, J. Bertrand +45 more
2018Journal of Antimicrobial Chemotherapy8 citations Open access
Semantic Scholar
The spectrum of HIV mother-to-child transmission risk
V. Reliquet, N. Winer, N. Chéreau, E. Launay +4 more
2014Journal of the International AIDS Society8 citations Open access
Semantic Scholar
A simple high performance liquid chromatography assay for monitoring plasma concentrations of tipranavir in HIV infected patients.
E. Dailly, V. Reliquet, C. Victorri-Vigneau, F. Raffi +1 more
2006Journal of chromatography. B, Analytical technologies in the biomedical and life sciences8 citations
Semantic Scholar
Neutrophil gelatinase-associated lipocalin, a marker of tubular dysfunction, is not increased in long-term virologically controlled patients receiving a tenofovir/emtricitabine + nevirapine regimen.
C. Allavena, K. Bach-Ngohou, E. Billaud, S. Secher +4 more
2013Journal of Antimicrobial Chemotherapy7 citations
Semantic Scholar
Stavudine plus didanosine and nevirapine in antiretroviral-naive HIV-infected adults: preliminary safety and efficacy results. VIRGO Study Team.
F. Raffi, V. Reliquet, C. François, M. Garré +7 more
1998Antiviral Therapy7 citations
Semantic Scholar
Previously unreported emergence of A265V substitution in the integrase gene in association with bictegravir virological failure.
E. Andre-Garnier, Q. Le Hingrat, A. Marcelin, V. Reliquet +7 more
2020International Journal of Antimicrobial Agents5 citations Open access
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

F. Raffi×32
Invite
F. Raffi — researcher profile on SciRah
C. Allavena×25
Invite
C. Allavena — researcher profile on SciRah
E. Billaud×23
Invite
E. Billaud — researcher profile on SciRah
P. Perré×13
Invite
P. Perré — researcher profile on SciRah

×12

Invite

S. Bouchez — researcher profile on SciRah

I. Poizot-Martin×11

Invite

I. Poizot-Martin — researcher profile on SciRah

E. Andre-Garnier×11

Invite

E. Andre-Garnier — researcher profile on SciRah

G. Peytavin×10

Invite

G. Peytavin — researcher profile on SciRah

C. Duvivier×10

Invite

C. Duvivier — researcher profile on SciRah

Invite

N. Hall — researcher profile on SciRah

A. Rodallec×10

Invite

A. Rodallec — researcher profile on SciRah

Invite

T. Guimard — researcher profile on SciRah